⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
COCP News
Cocrystal Pharma, Inc. Common Stock
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
globenewswire.com
COCP
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Presentation at ICAR 2026 Highlights Mechanism of Action and Clinical Advancement of CDI-988 for the Prevention and Treatment of Norovirus Infection
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
globenewswire.com
COCP
Form 8-K
sec.gov
COCP
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
globenewswire.com
COCP